According to filings with the U.S. Securities and Exchange Commission, Halda Therapeutics is raising up to $126,471,316.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Scott Phillips played a…
Six premier investors join syndicate for Series B extension to fund clinical trials of RIPTAC drug candidates for prostate cancer and breast cancer Initial clinical trial for first-in-class RIPTAC therapeutic in patients with metastatic castration-resistant…
According to filings with the U.S. Securities and Exchange Commission, Halda Therapeutics is raising up to $36,000,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Scott Phillips played a…
May 30, 2024 06:00 AM Pacific Daylight Time NEW HAVEN, Conn.–(BUSINESS WIRE)–Weave Bio, an AI-native life sciences platform company, announced the public release of its flagship offering, AutoIND, and seed funding of $10M co-led by Innovation…
According to filings with the U.S. Securities and Exchange Commission, Quantum Circuits is raising up to $27,000,000.00 in new funding. Sources indicate that as part of senior management President, Ray Smets played a key role…
According to filings with the U.S. Securities and Exchange Commission, Purpose Built Ventures Studio is raising up to $6,000,000.00 in new funding. Sources indicate that as part of senior management Senior Executive, Miles Lasater played…
According to filings with the U.S. Securities and Exchange Commission, Inbox Health is raising $22,499,997.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Blake Walker played a key role…
New Haven, CT – According to filings with the U.S. Securities and Exchange Commission, CoreChain Technologies is raising $5,759,533.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Christopher Aguas played…
New Haven, CT – According to filings with the U.S. Securities and Exchange Commission, Cybrexa is raising $53,724,407.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Per Hellsund played a…
New Haven, CT – According to filings with the U.S. Securities and Exchange Commission, Artizan Biosciences is raising $18,877,921.00 in new funding. Sources indicate as part of senior management President, Bridget Martell played a key…